Propranolol
- TRADE NAMES: Angilol; Apo-Propranolol; Apsolol; Detensol; Hemangeol (Pierre Fabre); Inderal (Wyeth); Inderal LA; Innopran XL
- INDICATIONS: Hypertension, angina pectoris, atrial fibrillation, myocardial infarction, migraine, tremor, infantile hemangioma
- CLASS: Antiarrhythmic, Antiarrhythmic class II, Beta adrenergic blocker, Beta blocker
- HALF-LIFE: 2–6 hours
Alcohol, Aluminum hydroxide, Aminophylline, Amiodarone, Barbiturates, Bupivacaine, Chlorpromazine, Cholestyramine, Cimetidine, Ciprofloxacin, Clonidine, Colestipol, Delavirdine, Diazepam, Dronedarone, Epinephrine, Ethanol, Fluconazole, Fluoxetine, Fluvoxamine, Haloperidol, Imipramine, Insulin, Insulin Detemir, Insulin Glargine, Insulin Glulisine, Isoniazid, Levothyroxine, Lidocaine, Neostigmine, Nicardipine, Nifedipine, Nilutamide, Nisoldipine, Oxtriphylline, Paroxetine Hydrochloride, Phenobarbital, Phenytoin, Propafenone, Pyridostigmine, Quinidine, Rifampin, Ritonavir, Rizatriptan, Sodium Iodide I-131, Teniposide, Terbutaline, Tolbutamide, Verapamil, Warfarin, Zileuton, Zolmitriptan
PREGNANCY CATEGORY: C
Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
